Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

June 01, 1996; Volume 49,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ali-Osman, F

    1. You have access
      Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;
  2. Antoun, G

    1. You have access
      Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;

B

  1. Bahouth, S W

    1. You have access
      Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;
  2. Basolo, F

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;
  3. Baur, R

    1. You have access
      Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;
  4. Bhama, J K

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  5. Blakely, R D

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  6. Boulanger, Y

    1. You have access
      Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;
  7. Buhr, A

    1. You have access
      Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;

C

  1. Chao, J

    1. You have access
      An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;
  2. Chaudhary, A

    1. You have access
      High affinity open channel block by dofetilide of HERG expressed in a human cell line.
      D J Snyders and A Chaudhary
      Molecular Pharmacology June 1996, 49 (6) 949-955;
  3. Chiba, P

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  4. Chik, C L

    1. You have access
      Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;
  5. Cobb, R R

    1. You have access
      D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;
  6. Cohen, S M

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  7. Cole, S P

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;
  8. Coon, M J

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  9. Coronel, E C

    1. You have access
      Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;
  10. Coutsogeorgopoulos, C

    1. You have access
      Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

D

  1. Danesi, R

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;
  2. Deeley, R G

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;
  3. Del Tacca, M

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;
  4. Ding, X

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  5. Domin, B

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  6. Drach, J

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;

E

  1. Ecker, G

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  2. Eling, T E

    1. You have access
      Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;

F

  1. Fain, J N

    1. You have access
      Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;
  2. Felts, K A

    1. You have access
      D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;
  3. Fernandez-Salguero, P

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  4. Forget, M A

    1. You have access
      Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;
  5. Fournier, A

    1. You have access
      Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;
  6. Fremeau, R T

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  7. Fukuchi, J

    1. You have access
      An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;

G

  1. Gagucas, E

    1. You have access
      Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;
  2. Gekeler, V

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  3. Gerlach, J H

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;
  4. Gershengorn, M C

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  5. Girvin, M E

    1. You have access
      Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;
  6. Glasgow, W C

    1. You have access
      Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;
  7. Gokmen-Polar, Y

    1. You have access
      Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
      S W Bahouth, Y Gokmen-Polar, E C Coronel and J N Fain
      Molecular Pharmacology June 1996, 49 (6) 1049-1057;
  8. Goldenberg, S

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  9. Gonzalez, F J

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  10. Guarnieri, F

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;

H

  1. Henzi, V A

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  2. Hill, E M

    1. You have access
      Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;
  3. Ho, A K

    1. You have access
      Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;
  4. Hockerman, G H

    1. You have access
      Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;
  5. Holý, A

    1. You have access
      Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

I

  1. Igarashi, K

    1. You have access
      An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;
  2. Irons, R D

    1. You have access
      Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;

J

  1. Jakobs, K H

    1. You have access
      A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
  2. Jeong, K S

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;

K

  1. Kallarakal, A T

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  2. Kallia-Raftopoulos, S

    1. You have access
      Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;
  3. Kashiwagi, K

    1. You have access
      An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;
  4. Kramata, P

    1. You have access
      Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

L

  1. Laakkonen, L

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  2. Laser, K T

    1. You have access
      A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
  3. Lebel, N

    1. You have access
      Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;
  4. Lee, I J

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  5. Li, W

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  6. Liu, P C

    1. You have access
      Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;

M

  1. Mackman, N

    1. You have access
      D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;
  2. Malbon, C C

    1. You have access
      Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;
  3. Malherbe, P

    1. You have access
      Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;
  4. Matsumura, F

    1. You have access
      Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;
  5. McGown, S R

    1. You have access
      Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;
  6. Meyer Zu Heringdorf, D

    1. You have access
      A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
  7. Miller, J W

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  8. Miras-Portugal, M T

    1. You have access
      Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;
  9. Moeller, K D

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  10. Myers, C E

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

N

  1. Nadler, J V

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  2. Nardini, D

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;

O

  1. Ogiwara, T

    1. You have access
      Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes.
      A K Ho, T Ogiwara and C L Chik
      Molecular Pharmacology June 1996, 49 (6) 1104-1112;
  2. Osman, R

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  3. Otová, B

    1. You have access
      Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;
  4. Ottenheijm, H C

    1. You have access
      Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

P

  1. Parry, G C

    1. You have access
      D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells.
      R R Cobb, K A Felts, G C Parry and N Mackman
      Molecular Pharmacology June 1996, 49 (6) 998-1004;
  2. Perlman, J H

    1. You have access
      Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
      L Laakkonen, W Li, J H Perlman, F Guarnieri, R Osman, K D Moeller and M C Gershengorn
      Molecular Pharmacology June 1996, 49 (6) 1092-1096;
  3. Phillips, M A

    1. You have access
      Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
      P C Liu, M A Phillips and F Matsumura
      Molecular Pharmacology June 1996, 49 (6) 989-997;
  4. Pyatt, D W

    1. You have access
      Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;

R

  1. Rajagopal, S

    1. You have access
      Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;
  2. Roberts, B J

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  3. Rodriguez-Pascual, F

    1. You have access
      Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;
  4. Ruoho, A E

    1. You have access
      Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket.
      G H Hockerman, M E Girvin, C C Malbon and A E Ruoho
      Molecular Pharmacology June 1996, 49 (6) 1021-1032;

S

  1. Samid, D

    1. You have access
      Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
      R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
      Molecular Pharmacology June 1996, 49 (6) 972-979;
  2. Schmid, D

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  3. Shafqat, S

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  4. Sheng, J J

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  5. Sigel, E

    1. You have access
      Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
      A Buhr, R Baur, P Malherbe and E Sigel
      Molecular Pharmacology June 1996, 49 (6) 1080-1084;
  6. Sirois, P

    1. You have access
      Biological and molecular analyses of structurally reduced analogues of endothelin-1.
      M A Forget, N Lebel, P Sirois, Y Boulanger and A Fournier
      Molecular Pharmacology June 1996, 49 (6) 1071-1079;
  7. Snyders, D J

    1. You have access
      High affinity open channel block by dofetilide of HERG expressed in a human cell line.
      D J Snyders and A Chaudhary
      Molecular Pharmacology June 1996, 49 (6) 949-955;
  8. Song, B J

    1. You have access
      Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439.
      I J Lee, K S Jeong, B J Roberts, A T Kallarakal, P Fernandez-Salguero, F J Gonzalez and B J Song
      Molecular Pharmacology June 1996, 49 (6) 980-988;
  9. Spink, D C

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  10. Stillman, W S

    1. You have access
      Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells.
      D W Pyatt, W S Stillman and R D Irons
      Molecular Pharmacology June 1996, 49 (6) 1097-1103;
  11. Stride, B D

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;
  12. Synetos, D

    1. You have access
      Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;

T

  1. Tell, B

    1. You have access
      Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
      P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg and V Gekeler
      Molecular Pharmacology June 1996, 49 (6) 1122-1130;
  2. Tomer, K B

    1. You have access
      Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.
      W C Glasgow, E M Hill, S R McGown, K B Tomer and T E Eling
      Molecular Pharmacology June 1996, 49 (6) 1042-1048;
  3. Torres, M

    1. You have access
      Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
      F Rodriguez-Pascual, M T Miras-Portugal and M Torres
      Molecular Pharmacology June 1996, 49 (6) 1058-1070;

V

  1. Valdimarsson, G

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;
  2. van den Broek, L A

    1. You have access
      Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation.
      S Kallia-Raftopoulos, D Synetos, H C Ottenheijm, L A van den Broek and C Coutsogeorgopoulos
      Molecular Pharmacology June 1996, 49 (6) 1085-1091;
  3. Van Koppen, C J

    1. You have access
      A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
  4. Vaz, A D

    1. You have access
      Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450.
      X Ding, D C Spink, J K Bhama, J J Sheng, A D Vaz and M J Coon
      Molecular Pharmacology June 1996, 49 (6) 1113-1121;
  5. Velaz-Faircloth, M

    1. You have access
      A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter.
      R T Fremeau, M Velaz-Faircloth, J W Miller, V A Henzi, S M Cohen, J V Nadler, S Shafqat, R D Blakely and B Domin
      Molecular Pharmacology June 1996, 49 (6) 1033-1041;
  6. Votruba, I

    1. You have access
      Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon.
      P Kramata, I Votruba, B Otová and A Holý
      Molecular Pharmacology June 1996, 49 (6) 1005-1011;

W

  1. Wang, H

    1. You have access
      Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
      F Ali-Osman, G Antoun, H Wang, S Rajagopal and E Gagucas
      Molecular Pharmacology June 1996, 49 (6) 1012-1020;
  2. Williams, K

    1. You have access
      An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
      K Kashiwagi, J Fukuchi, J Chao, K Igarashi and K Williams
      Molecular Pharmacology June 1996, 49 (6) 1131-1141;
  3. Wilson, G M

    1. You have access
      Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.
      B D Stride, G Valdimarsson, J H Gerlach, G M Wilson, S P Cole and R G Deeley
      Molecular Pharmacology June 1996, 49 (6) 962-971;

Z

  1. Zhang, C

    1. You have access
      A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils.
      C J Van Koppen, D Meyer Zu Heringdorf, C Zhang, K T Laser and K H Jakobs
      Molecular Pharmacology June 1996, 49 (6) 956-961;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 49, Issue 6
1 Jun 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics